ArticlePreventive medicine2013
Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.
Article in Preventive medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.American journal of obstetrics and gynecology · 2014Trial
- Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.Journal of women's health (2002) · 2014Trial
- Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.Analytical methods : advancing methods and applications · 2026Article
- Evaluation of an intelligent digital platform for population management in cervical cancer screening.Cancer biology & medicine · 2025Observational
- Impact of management guidelines for abnormal cervical cytology on colposcopy procedure rates among young women.Gynecologic oncology · 2024Article
- Clinician practices, knowledge, and attitudes regarding primary human papillomavirus testing for cervical cancer screening: A mixed-methods study in Indiana.Preventive medicine reports · 2023Article
- Article
- The Impact of Continuity of Care on Cervical Cancer Screening: How Visit Pattern Affects Guideline Concordance.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022Article
- Awareness and Support of Clinician- and Patient-Collected Human Papillomavirus Testing for Cervical Cancer Screening Among Primary Care Clinicians.Women's health reports (New Rochelle, N.Y.) · 2022Article
- Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.JAMA network open · 2021Article
- Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses.PloS one · 2020Article
- Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.BMC women's health · 2018Article
- Racial/Ethnic Disparities in Cervical Cancer Screening Services Among Contractors of the Connecticut Breast and Cervical Cancer Early Detection Program.Health equity · 2018Article
- Article
- Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.Obstetrics and gynecology · 2016Article
- Changes in Knowledge and Beliefs About Human Papillomavirus and Cervical Cancer Screening Intervals in Low-Income Women After an Educational Intervention.Journal of primary care & community health · 2016Article
- Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.International journal of cancer · 2015Article
- Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.Cancer causes & control : CCC · 2015Article
- Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.Journal of women's health (2002) · 2015Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
objectiveCervical cancer screening using the human papillomavirus (HPV) test and Pap test together (co-testing) is an option for average-risk women ≥ 30 years of age. With normal co-test results, screening intervals can be extended. The study objective is to assess primary care provider practices, beliefs, facilitators and barriers to using the co-test and extending screening intervals among low-income women.
methodData were collected from 98 providers in 15 Federally Qualified Health Center (FQHC) clinics in Illinois between August 2009 and March 2010 using a cross-sectional survey.
results39% of providers reported using the co-test, and 25% would recommend a three-year screening interval for women with normal co-test results. Providers perceived greater encouragement for co-testing than for extending screening intervals with a normal co-test result. Barriers to extending screening intervals included concerns about patients not returning annually for other screening tests (77%), patient concerns about missing cancer (62%), and liability (52%).
conclusionAmong FQHC providers in Illinois, few administered the co-test for screening and recommended appropriate intervals, possibly due to concerns over loss to follow-up and liability. Education regarding harms of too-frequent screening and false positives may be necessary to balance barriers to extending screening intervals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.